Latest AI and machine learning research in oncology/hematology for healthcare professionals.
ATP-binding cassette (ABC) transporters ABCB1/P-glycoprotein (P-gp) and ABCG2/breast cancer resistan...
BackgroundLarge language model (LLM)-based generative artificial intelligence (AI) tools have rapidl...
BACKGROUND: Survivorship care plans (SCPs) summarize cancer treatment and guide risk-based follow-up...
Introduction Early-stage proximal caries detection on bitewing radiographs is challenging and hamper...
Pancreatic ductal adenocarcinoma (PDAC), with a 12% 5-year survival rate, is the most aggressive typ...
INTRODUCTION: Oral squamous cell carcinoma (OSCC) and oral leukoplakia (OLK) impose a growing diagno...
INTRODUCTION: Breast cancer is a heterogeneous malignancy comprising distinct molecular subtypes, ea...
Purpose ： Deep learning has shown great promise in medical image analysis, yet challenges remain in ...
Cancer immunotherapy has revolutionized the treatment landscape, yet its clinical efficacy is limite...
OBJECTIVE: Glioblastoma (GBM) is a lethal tumor where temozolomide (TMZ) chemotherapy often faces re...
Cellular senescence (CS) exerts dual roles in tumorigenesis, yet its pan-cancer molecular characteri...
PURPOSE: Patient-reported outcome measures (PROMs) are central to evaluating quality of life (QoL) i...
Pancreatic ductal adenocarcinoma (PDA) is profoundly immunosuppressive. To help define this behavior...
BACKGROUND: Early detection of esophageal squamous cell carcinoma (ESCC) is critical, but Lugol chro...
BACKGROUND: The management of hepatocellular carcinoma (HCC) relies on decisions formulated by a mul...
BACKGROUND: Heterogeneous circulating tumor cell (CTC) clusters interact with platelets, neutrophils...
Pancreatic adenocarcinoma (PAAD) is an immunosuppressive malignancy refractory to radiotherapy and i...
Drug discovery relies on cellular assays to determine whether a candidate produces a desired respons...
Breast cancer, particularly hormone receptor-positive (HR+) and triple-negative (TNBC) subtypes, is ...
BACKGROUND: Patient-derived organoids (PDOs) provide physiologically relevant 3D tumor models for pr...
Artificial intelligence (AI) has become a pivotal driver of innovation in cancer immunotherapy throu...